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Patients and methods: This prospective study included 100 patients with abdominal pain or mass.
MDCT examination of the abdomen was performed for all the patients using 16-detector MDCT
scanner (Bright Speed 16; GE medical systems). The axial and MPR images were interpreted for
nodal size, morphology, number, distribution, and associated groups of LN. Histopathological
examination of the biopsied nodes was performed for confirmation.
Results: Based on nodal size criterion, nodes were classified into two groups: normal in 68% and
pathologic in 32%. Most of normal nodes were oval shape (88.2%), multiple (85%) and located at
the root of the mesentery (70.6 %). Most of pathologic nodes were well-defined (62.5%), rounded
shape (37.5%) with lobulated margins (43.75%). They were multiple (68.7%), located at the root of
the mesentery (87.5 %) and enhanced (75%). Central necrosis was detected in 6 patients, calcifica-
tion in 5 patients and extra-nodal spread in 12 patients. The associated other groups of abdominal
lymph node enlargement were detected in 26 patients.
Conclusion: The MDCT has a great role in characterization of mesenteric lymph node which helps
in differentiation between normal and pathological groups based on many MDCT criteria.
 2016 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).1. Introduction
Mesenteric lymph nodes are the 100–150 lymph nodes that lie
between layers of the mesentery that accompany the branches
of the superior mesenteric artery and vein and are located
within the mesenteric fat (1). Normal mesenteric lymph
nodes may be routinely identified at the mesenteric root and
throughout mesentery in particular; at Rt. iliac fossa in
children (2) and at the mesenteric root in adults (3).
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to mesenteric lymphadenopathy. The most common causes of
mesenteric lymphadenopathy are neoplastic, inflammatory,
and infectious (4).
With the advent of multi-detector computed tomography
(MDCT) routine evaluation of mesenteric lymph nodes is
now possible. With the increasing volume of cross-sectional
imaging being performed, lymph nodes in the mesentery are
being detected with increasing frequency (4).
Normal mesenteric lymph node appears as round or oval
soft tissue masses that appear and disappear over several
images and enhances slightly more than the adjacent muscle
on CT (4). Mesenteric lymph nodes with a mean maximum
short-axis dimension of 4.6 mm are considered normal at
CT (3).
The most widely accepted and frequently used criterion for
determination of nodal involvement is the size criterion (5). In
addition, it is important to remember that the size of the nodes
alone does not always reflect disease, but morphology, number
and distribution of lymph nodes are also important (3).
So the aim of our study was detection and characterization
of mesenteric lymphadenopathy using multi-detector com-
puted tomography.2. Patients and methods
2.1. Patients
This study was approved by the ethics committee of our insti-
tution during the period between March 2014 and July 2015,
and all the patients had an informed consent. This study
included 100 patients referred from the oncology and surgery
clinics. They were either complained of abdominal pain or
abdominal mass or incidentally presented for other investiga-
tions. Their ages ranged from 20 to 73 with a mean value of
51.22 ± 25.6 years. They were fifty-eight males (58%) and
forty-two females (42%).
2.2. Technique of MDCT abdomen
2.2.1. Patient preparation
All the patients were given 1000 ml of oral contrast agent
[1–2% diluted water soluble iodinated contrast agent, meglu-
mine diatrizoate (Gastrografin)] 2-h before the examination,
provided that patients were fasting for 6 h.
2.2.2. Imaging acquisition and scanning parameters
MDCT examination of the abdomen and pelvis was performed
for all the patients using 16-detector MDCT scanner (Bright
Speed 16; GE medical systems). The examination included
unenhanced and enhanced scans. The unenhanced scan was
performed to detect calcified mesenteric lymph node. The post
contrast study was performed after intravenous bolus injection
of 80 ml of nonionic contrast agent (300 mg/mL, Omnipaque
300) at a flow rate of 4 ml/s using power injector (Medrad,
Stellant) through 20 gauge catheter into the anti-cubital vein
using time bolus tracking technique. Imaging was performed
during the portal venous phase with a delay of 60–70 s used
in all cases. The images were obtained from the level of the
dome of diaphragm to the symphysis pubis. The axial sourceimages were taken at a 1.25 mm section thickness and a
1.25 mm interval with the following acquisition scanning
parameters: 420 mAs, 100 kVp, 12.7 s total exposure time, a
helical pitch of 1.375:1, 0.8 s scan time, 16  1.25 mm detector
configuration.
2.2.3. Image reconstruction
The axial source images with a 1.25 mm slice thickness were
transferred to an Advantage workstation (AW) volume share
2 (GE Healthcare) for image reconstructions. Multi-planner
reformatted images were obtained in coronal and sagittal
planes with a section thickness of 1.25 mm.
2.2.4. Imaging analysis
The nodes were classified into two groups (normal and patho-
logic) according to the size criterion with a mean maximum
short-axis dimension of 4.6 mm which was considered the
cutoff value above which the nodes were considered patho-
logic, and this was based on the previous study of Lucey
et al. (3). Besides the size criterion, all the MDCT images were
interpreted for the other MDCT criteria of mesenteric LN
including the following:
– Morphology (definition, margin, shape)
– Enhancement pattern
– Calcification
– Central necrosis
– Extra nodal spread
– Distribution
– Number
– Associated other groups of abdominal LN.
2.3. Biopsy and histopathological examination
Biopsy was performed for all the thirty-two patients with
mesenteric lymph node enlargement (pathologic group). They
were subjected to biopsy procedures in the form of fine needle
aspiration for 9 patients, true cut needle biopsy for 15 patients,
and excisional biopsy for 8 patients. Pathological examination
of the biopsied specimen was performed for confirmation of
the pathologic cause.
2.4. Statistical analysis
Data entry was done by SPSS version 11. Frequency distribu-
tion, descriptive statistics and correlation analysis were done
using v2 and Fisher exact tests for qualitative data. The prob-
ability (p value) of less than 0.05 is used as a cutoff point for all
significant tests. The sensitivity, specificity, PPV, NPV and
accuracy of MDCT in differentiating benign from malignant
lymph nodes were calculated.
3. Results
Based on nodal size criterion (cutoff value of 4.6 mm), we
found that normal mesenteric lymph nodes were encountered
in 68 (68%) out of 100 patients and pathologically enlarged
mesenteric lymph nodes were encountered in 32 (32%) out
of 100 patients (Table 1). The size of normal mesenteric nodes
Table 1 Normal and pathological mesenteric lymph nodes
based on the size criteria (cutoff value 4.6 mm) (n= 100).
Short axis diameter of the lymph node Number Percent
Less than 4.6 mm 68 68
More than 4.6 mm 32 32
Table 2 The range and mean size of the normal and
pathological groups of mesenteric lymphadenopathy (n= 100).
Size of node Statistical data p value
Normal Range 1.0–4.6 mm 0.02
Mean 2.96 mm
Pathological Range 4.7 mm–9 cm
Mean 19 mm
p value is considered significant if less than 0.05.
Table 3 Characteristic MDCT features of normal group of
mesenteric lymph nodes (n= 68).
MDCT criteria Number Percent
Shape
– Oval 60 88.2
– Rounded 8 11.8
Enhancement pattern
– Non-enhanced 26 38.2
– Homogenous enhancement 42 61.8
Number
– Multiple 58 85.3
– Single 10 14.7
Distribution
– Root of the mesentery 48 70.6
– Periphery of the mesentery 20 29.4
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(Fig. 1), while the size of pathologic mesenteric nodes ranged
from 4.7 mm to 9 cm with a mean value of 19 mm. There
was a statistically significant difference between the size of
normal and pathologically enlarged mesenteric lymph nodes
(p= 0.02) (Table 2).
Regarding the MDCT criteria of normal mesenteric lymph
node group we found that, most of normal mesenteric lymph
nodes were oval shape, as they were encountered in 60
(88.2%) out of 68 patients, multiple in number representing
58 (85%) out of 68 patients and located at the root of the
mesentery representing 48 (70.6%) out of 68 patients (Table 3).
According to The MDCT criteria of the pathologic mesen-
teric lymph node group (n= 32) we determined that most of
the pathologic mesenteric LN were well defined (62.5%),
rounded in shape (37.5%) with lobulated margins (43.75%).
Most of the detected pathologic mesenteric lymph nodes were
multiple in number encountered in 22 (68.7%) out of 32
patients and located at the root of the mesentery in 28
(87.5%) out of 32 patients. Most of them were enhanced rep-
resenting 75%, they exhibit different enhancement patterns,
the most common pattern was homogenous enhancement
which was encountered in 14 (58.3%) out of 24 patients. Cen-
tral necrosis was detected in 6 (42.8%) out of 14 patients with
metastatic nodes and calcification was noted only in 5 (15.6%)
out of 32 patients. One of the important MDCT criteria was
the demonstration of extra-nodal spread in the form of a)
encasement of mesenteric vessels in 8 (66.7%) out of 12
patients and b) invasion of mesenteric vessels in 4 (33.3%)
out of 12 patients. The last MDCT criteria was the association
of other groups of abdominal lymph node enlargement that
was detected in 26 (81.2%) out of 32 patients (Table 4).
According to pathological verification, the causes of
enlarged mesenteric LN (n= 32) were classified into non-Fig. 1 30-year-old female patient presented with abdominal pain and
the abdomen and pelvis show multiple small oval smooth borders norm
diameter (arrows in a–c) seen in the root of the mesentery along the cneoplastic and neoplastic causes. Non-neoplastic causes were
detected in 6 (18.75%) out of 32 patients, and they were fur-
ther classified into inflammatory causes included appendicitis,
Crohn’s disease, and proctocolitis and infectious causes in the
form of TB. Neoplastic causes were detected in 26 (81.25%)
out of 32 patients, and the most common neoplastic cause
was lymphoma as it was detected in 12 (46.2%) out of 26
patients. Other neoplastic causes are enumerated in Table 5
(Figs. 2–5).distention. (a) axial, (b) coronal, and (c) sagittal MPR images of
al mesenteric lymph nodes less than 4.6 mm in maximum short axis
ourse of the mesenteric vasculature (white block arrow in b).
Table 4 Characteristic MDCT features of pathological group
of mesenteric lymphadenpathy (n= 32).
MDCT criteria Number Percent
Morphology
– Definition
Ill-defined 12 37.5
Well defined 20 62.5
– Borders
Smooth 12 37.5
Irregular 6 18.75
Lobulated 14 43.75
– Shape
Oval 7 21.87
Rounded 12 37.5
Amalgamated 13 40.62
Number
– Multiple 22 68.7
– Single 10 31.3
Distribution
– Root of the mesentery 28 87.5
– Periphery of the mesentery 4 12.5
Enhancement
– Enhanced 24 75
– Not enhanced 8 25
Pattern of enhancement
– Homogenous 14 58.3
– Heterogeneous 4 16.6
– Mixed peripheral 6 25
Central necrosis 6 42.8
Calcification
– Positive 5 15.6
– Negative 27 84.3
Extra nodal spread 12 37.5
– Encasement of mesenteric vessels 8 66.7
– Invasion to mesenteric vessels 4 33.3
Associated other groups of abdominal lymph
nodes
26 81.2
Table 5 Causes of pathologically enlarged mesenteric lymph
nodes (n= 32).
Pathological causes Number Percent
Non-neoplastic causes
Inflammatory
– appendicitis 1 16.6
– crohn’s disease 1 16.6
– Procto colitis 2 33.3
Infectious
– T.B 2 33.3
Total 6 18.75
Neoplastic causes
– Lymphoma 12 46.3
– Colonic carcinoma 4 15.3
– Breast carcinoma 4 15.3
– Gastrointestinal carcinoid tumor 2 7.7
– Adenocarcinoma of the pancreas 2 7.7
– Ovarian carcinoma 2 7.7
Total 26 81.25
760 E.A. Abdel Gawad et al.MDCT was accurate (83.6%) in differentiating benign from
malignant lymph nodes with a sensitivity of (72.6%) and
specificity of (68.3%) Table 6.
4. Discussion
It is important to recognize mesenteric lymphadenopathy in
patients with history of primary carcinoma because lym-
phadenopathy affects staging of the disease, which in turn will
affect further management. In addition, mesenteric lym-
phadenopathy may be the only indicator of an underlying
inflammatory or infectious process causing abdominal
pain (4).
In our study the mesenteric lymph nodes were classified
into normal and pathological groups according to the size cri-
terion which is the most important morphological feature,
4.6 mm was the cutoff value used for distinguishing between
normal sized and enlarged mesenteric lymph nodes, and this
was based on the previous report documented by Lucey
et al. (3). According to size criterion our results revealed thatnormal mesenteric lymph nodes were encountered in 68
(68%) out of 100 patients and pathologically enlarged mesen-
teric lymph nodes were encountered in 32 (32%) out of 100
patients. There was a statistically significant difference between
the size of normal and pathologically enlarged mesenteric
lymph nodes (p= 0.02). The mean maximum short axis diam-
eter of normal mesenteric lymph was 2.96 mm and ranged
from 1.0 mm to 4.6 mm while that of the pathologic nodes
was 19 mm and ranged from 4.7 mm to 9 cm, and these mea-
sures were based on and in accordance with Lucey et al. (3)
who estimate the mean size of mesenteric lymph nodes in 47
patients who were presented to the emergency department
after experiencing blunt abdominal trauma; the mean size of
the largest nodes was 4.8 mm (range, 3–9 mm). Pathological
group of mesenteric nodes may reach very large size as they
are matted together forming huge nodal mass as in case of
lymphoma and TB (6).
The main drawbacks depending upon the size criterion
alone were addressed by Sahani (5) who reported that the
major limitation of this criterion is the inability to detect meta-
static involvement in normal-sized nodes and inability to dif-
ferentiate reactive and hyperplastic nodal enlargement from
malignant nodes. These drawbacks may lead to underestimat-
ing or overestimating the presence of the disease. So depending
on other MDCT criteria such as number and distribution com-
bined with size criterion is ideal for better differentiation.
The incidence (68%) of normal sized mesenteric lymph
node in this study was higher than that of Lucey et al. (3)
which was 39%, and this can be explained by that all our
CT examinations were performed using a 16-detector with a
thinner section thickness of 1.25 mm and a reconstruction
interval of 1.25 mm, which permits more frequent detection
of small lymph nodes compared with Lucey study (3) in which
all the CT examinations were performed using a 4-MDCT
scanner with a slice collimation of 3.2 mm, and a reconstruc-
tion interval of 3 mm. The MDCT criteria of normal nodes
included the shape, enhancement pattern, number and distri-
bution. The result of this study revealed that most of lymph
nodes were oval in shape representing (88.2%) this was in
Fig. 2 64-year-old male patient presented with abdominal pain and distention. (a and b) axial, and (c) coronal MPR images of the
abdomen and pelvis show multiple well-defined lobulated enlarged calcified mesenteric lymph nodes average size measures 20 mm (white
arrows in a–c) seen distributed in the root of the mesentery and the diffusely thickened dilated bowel loops show enhanced walls (white
block arrows in a–c). Histopathologically proved to be proctocolitis.
Fig. 3 56-year-old male patient presented with abdominal pain. (a–c) Multiple axial MDCT images of the abdomen and pelvis show
multiple rounded and oval with irregular borders not enhanced enlarged mesenteric lymph nodes seen matted together in the root of the
mesentery (white arrows in a–c) encasing the superior mesenteric artery (white block arrow in a and b), producing the ‘‘sandwich sign”.
Histopathologically proved to be Non-Hodgkin’s lymphoma.
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normal lymph node tends to be oval in shape while metastatic
lymph node is rounded. The normal nodes were multiple rep-
resenting 85.3%, which is in agreement with Lucey et al. (3)
who reported that, in healthy population, when mesenteric
lymph nodes are present, they are usually multiple, with nearly
half (47%) of these patients having five or more nodes
detected. He also addressed that small lymph nodes are fre-
quently detected (68%) at the mesenteric root, and we also
found that most of normal nodes (70.6%) are distributed in
the root of mesentery.
According to MDCT criteria of pathological mesenteric
lymph node group, that was presented in (32%), we deter-
mined that most of our patients have well defined (62.5%),
lobulated (43.75%) and amalgamated (37.5%) mesenteric
lymph node and this was attributed to the fact that the most
common pathologic cause in this study was lymphoma
(46.2%), which was in comparable with Lucey et al. (4) who
reported that the mesenteric lymph nodes which were affected
by lymphoma often coalesce, forming a conglomerate lobu-
lated soft-tissue mass. We also found that most of pathologi-cally enlarged mesenteric lymph nodes attain rounded shape
representing 37.5% and this was explained by the fact that
14 out of 26 patients with neoplastic causes of LN enlargement
had metastatic nodes, which was in accordance with Som and
Brandwein (7) who reported that most of metastatic nodes
were rounded in shape.
Nodal enhancement seems to imply increased nodal vascu-
larity. At MDCT, the appearance of mesenteric nodes after
contrast material administration may aid in identifying the
underlying cause, although the enhancement patterns of differ-
ent entities can overlap and suggest wide differential diagnosis
(8). In this study the most common pattern of enhancement
was homogenous enhancement (58.3%) and this can be attrib-
uted to lymphoma (46.2%) which is the most common pathol-
ogy in our study. Pombo et al. (9) and Hopper et al. (10) also
reported that lymphoma is the commonest malignant pathol-
ogy that affects the mesentery, which shows homogenous
enhancement on post-contrast CT.
The best radiological predictor of lymph node metastasis is
central necrosis. In our study, central necrosis with peripheral
enhancement was detected in 6 (42.8%) out of 14 patients with
Fig. 4 35-year-old male patient with history of cervical lymph node enlargement. (a and b) axial, and (c) coronal MPR images of the
abdomen and pelvis show multiple well-defined rounded enlarged mesenteric lymph nodes average size measures 15 mm (white arrows in
a–c) seen distributed in the root of the mesentery with no invasion to mesenteric vessels (white block arrow in a and b) Histopathologically
proved to be follicular lymphoma.
Fig. 5 39-year-old female patient presented with abdominal mass. (a and b) axial MDCT images of the abdomen and pelvis show
extensive mural thickening of mid-transverse colon consistent with tumoral infiltration (white arrow in a). This is associated with multiple
enlarged mesenteric and para-aortic lymph nodes (white arrow in b), they show central necrosis and peripheral enhancement.
Histopathologically proved to be colonic carcinoma with nodal metastases.
Table 6 Sensitivity, specificity and accuracy of MDCT in
differentiating benign from malignant lymph nodes (n= 100).
Sensitivity
(%)
Specificity
(%)
PPV
(%)
NPV
(%)
Accuracy
(%)
72.6 68.3 64.6 71.3 83.6
762 E.A. Abdel Gawad et al.metastatic nodes. King et al. (11) reported that nodal necrosis
is the most reliable sign of metastatic node with an accuracy of
MDCT of 93%.
The extra nodal spread is a grave prognostic finding. In our
study the extra nodal spread was detected in 12 (37.5%) out of
32 patients in the form of encasement of mesenteric vessels
which was detected in 8 (66.7%) out of 12 patients andinvasion of mesenteric vessels that was detected in 4 (33.3%)
out of 12 patients. Encasement of superior mesenteric artery
forms a characteristic sign which is ‘‘sandwich-sign”. It was
created by the lobulated, confluent mesenteric soft-tissue
masses that resemble two halves of a sandwich and the tubular
structures of mesenteric vessels and perivascular fat that
resembles the sandwich filling. This sign is usually seen in
patients with lymphoma of the mesentery. Mueller et al. (12)
and Yang et al. (13) also postulated that neoplastic involve-
ment of the mesentery can be diagnosed in lymphoma on the
basis of a characteristic appearance of ‘‘sandwich-sign” encase-
ment of the superior mesenteric artery. The second pattern of
extra-nodal spread was the invasion to mesenteric vessels
that was identified on contrast-enhanced CT by thickened
nodal rim with infiltration of the adjacent plane. This was
CT in detection and characterization of mesenteric lymphadenopathy 763based on Som and Brandwein (7) who postulated that such
extra-nodal spread is less reliably identified in MRI than in
CT. This may simply be due to the fact that the low
attenuation of fat on CT is the best background to identify
such early nodal changes.
The last MDCT criterion that was evaluated in our study
was the association of other groups of abdominal lymph nodes
enlargement; we found that most of mesenteric LN enlarge-
ments were associated with peri-pancreatic, para-aortic,
retroperitoneal and iliac lymph nodes, representing 81.2%.
This can be explained by the fact that the mesenteric lym-
phadenopathy rarely presents alone whatever its pathologic
causes as lymphoma, TB, and metastasis from primary tumors.
In this study 12 (46.2%) out of the 26 patients had lymphoma,
and multiplicity of abdominal lymph nodal enlargement with
lymphoma was also addressed by Yenarkan et al. (14) who
reported that the clue for diagnosis of lymphoma of the mesen-
tery was the prominent mesenteric lymphadenopathy associ-
ated with other groups mostly retroperitoneal lymph nodes.
According to the pathological examination the enlarged
mesenteric lymph nodes were classified into non-neoplastic
and neoplastic causes. In our study, non-neoplastic nodes were
detected in 6 (18.75%) out of 32 patients. Neoplastic causes
were detected in 26 (81.25%) out of 32 patients; they were clas-
sified into Lymphoma and metastasis from primary tumors
such as colonic carcinoma (15.3%), breast carcinoma
(15.3%). In this study the most common malignant cause
affecting the mesenteric lymph node was lymphoma represent-
ing 46.2%, which was in agreement with many previous studies
as Cole (15), Mueller et al. (12), and Yang et al. (13) who
reported that the most common malignancy resulting in
mesenteric lymphadenopathy is lymphoma, and also it is the
most common cause of mesenteric masses. Horton et al. (16)
and Hardy et al. (17) also reported that most cases of mesen-
teric lymphadenopathy are associated with non-Hodgkin lym-
phoma rather than with epithelial tumors. Mesenteric
involvement is the predominant finding in 4–5% of patients
with Hodgkin lymphoma and in 30–50% of patients with
non-Hodgkin lymphoma (18,19).
In this study the second most common malignant cause
affecting mesenteric lymph nodes is metastasis from colonic
(15.3%.) and breast carcinoma (15.3%). This was in agreement
with other studies Hansen et al. (20), Shirkhoda et al. (21), and
Chintapalli et al. (22) and they reported that primary
malignancies that more commonly result in mesenteric
lymphadenopathy include carcinoma of the breast (20) and
gastrointestinal tract (21,22).
The overall diagnostic accuracy of MDCT in differentiating
benign from malignant lymph nodes in our study was 83.6%;
similar value was also reported by Kanamoto et al. (23) who
concluded that the MDCT was effective for evaluation of
lymph nodes metastasis of colorectal cancer with overall
80.5%. A recent study of Saito et al. (24) documented that
the total accuracy of multidetector-row CT in diagnosing
lymph node metastasis in patients with gastric cancer was
76.6%.
The main limitation of our study is that it relied mainly on
the size criterion in differentiating normal from pathologic
mesenteric lymph nodes, although it is the most widely used
CT criteria; however, it had a major limitation which is its
inability to detect metastasis in normal-sized nodes that may
lead to understaging of the malignant diseases.5. Conclusion
The MDCT has a great role in characterization of mesenteric
lymph node which helps in differentiation between normal and
pathologic mesenteric lymph nodes and between different
causes of mesenteric nodal enlargement based on many
MDCT criteria such as the morphology, distribution, and
enhancement pattern that may give an indication of the under-
lying pathologic condition. So we recommend that whenever
possible, MDCT examination should be performed prior to
any nodal biopsy procedures.
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